2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters

2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters

Submitted by admin on February 9, 2010 - 10:58am
Source: 
BNET Pharma
News Tags: 
FDA
Cadence Pharmaceuticals
Acorda Therapeutics
Auxilium
Gilead Sciences
Shire
Amylin
Cell Therapeutics
Dendreon
InterMune
Amgen
Human Genome
NicOx
Vivus
Arena Pharmaceuticals
Orexigen
Headline: 
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters

Do Not Allow Advertisers to Use My Personal information